Correlation Between Elixinol Global and Rafarma Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Elixinol Global and Rafarma Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Elixinol Global and Rafarma Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Elixinol Global and Rafarma Pharmaceuticals, you can compare the effects of market volatilities on Elixinol Global and Rafarma Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Elixinol Global with a short position of Rafarma Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Elixinol Global and Rafarma Pharmaceuticals.

Diversification Opportunities for Elixinol Global and Rafarma Pharmaceuticals

0.2

Correlation Coefficient

Elixinol Global  Rafarma Pharmaceuticals

Modest diversification

The 3 months correlation between Elixinol and Rafarma is 0.2. Overlapping area represents the amount of risk that can be diversified away by holding Elixinol Global and Rafarma Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rafarma Pharmaceuticals and Elixinol Global is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Elixinol Global are associated (or correlated) with Rafarma Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rafarma Pharmaceuticals has no effect on the direction of Elixinol Global i.e., Elixinol Global and Rafarma Pharmaceuticals go up and down completely randomly.

Pair Corralation between Elixinol Global and Rafarma Pharmaceuticals

Assuming the 90 days horizon Elixinol Global is expected to generate 8.02 times more return on investment than Rafarma Pharmaceuticals. However, Elixinol Global is 8.02 times more volatile than Rafarma Pharmaceuticals. It trades about 0.15 of its potential returns per unit of risk. Rafarma Pharmaceuticals is currently generating about 0.03 per unit of risk. If you would invest  0.35  in Elixinol Global on September 17, 2024 and sell it today you would earn a total of  0.15  from holding Elixinol Global or generate 42.86% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	99.66%
Values	Daily Returns

Elixinol Global  vs.  Rafarma Pharmaceuticals

Elixinol Global

Risk-Adjusted Performance

12 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Elixinol Global are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite nearly unsteady basic indicators, Elixinol Global reported solid returns over the last few months and may actually be approaching a breakup point.

Rafarma Pharmaceuticals

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Rafarma Pharmaceuticals are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite somewhat fragile technical and fundamental indicators, Rafarma Pharmaceuticals sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Elixinol Global and Rafarma Pharmaceuticals

The main advantage of trading using opposite Elixinol Global and Rafarma Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Elixinol Global position performs unexpectedly, Rafarma Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rafarma Pharmaceuticals will offset losses from the drop in Rafarma Pharmaceuticals' long position.

The idea behind Elixinol Global and Rafarma Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.